Trial Profile
Mechanisms of Reduced Ramipril on the Onset of Type 2 Diabetes Mellitus.
Status:
Discontinued
Phase of Trial:
Phase 0
Latest Information Update: 13 Sep 2019
Price :
$35
*
At a glance
- Drugs Ramipril (Primary) ; Hydrochlorothiazide
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 01 Dec 2014 Status changed from recruiting to discontinued, as reported by ClinicalTrials.gov.
- 27 May 2014 Planned End Date changed from 1 Dec 2014 to 1 Dec 2015 as reported by ClinicalTrials.gov.
- 03 May 2013 Status changed from active, no longer recruiting to recruiting as reported by ClinicalTrials.gov.